Analysis of the association between CFH Y402H polymorphism and response to intravitreal ranibizumab in patients with neovascular age-related macular degeneration (nAMD). Biomol Biomed [Internet]. 2018 Aug. 1 [cited 2024 May 5];18(3):260-7. Available from: https://www.bjbms.org/ojs/index.php/bjbms/article/view/2493